These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18519928)

  • 1. Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003.
    Tanaka H; Imai Y; Hiramatsu N; Ito Y; Imanaka K; Oshita M; Hijioka T; Katayama K; Yabuuchi I; Yoshihara H; Inoue A; Kato M; Takehara T; Tamura S; Kasahara A; Hayashi N; Tsukuma H
    Ann Intern Med; 2008 Jun; 148(11):820-6. PubMed ID: 18519928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma.
    Lee MH; Yang HI; Lu SN; Jen CL; You SL; Wang LY; L'Italien G; Chen CJ; Yuan Y;
    Int J Cancer; 2014 Sep; 135(5):1119-26. PubMed ID: 24482200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging of patients with hepatitis C virus-associated hepatocellular carcinoma: long-term trends in Japan.
    Taura N; Hamasaki K; Nakao K; Ichikawa T; Nishimura D; Goto T; Fukuta M; Kawashimo H; Miyaaki H; Fujimoto M; Kusumoto K; Motoyoshi Y; Shibata H; Inokuchi K; Eguchi K
    Oncol Rep; 2006 Oct; 16(4):837-43. PubMed ID: 16969503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma: recent trends in Japan.
    Kiyosawa K; Umemura T; Ichijo T; Matsumoto A; Yoshizawa K; Gad A; Tanaka E
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S17-26. PubMed ID: 15508082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus.
    Tanaka H; Tsukuma H; Yamano H; Oshima A; Shibata H
    Int J Cancer; 2004 Dec; 112(6):1075-80. PubMed ID: 15386355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of NonBNonC- HCC: Comparison with HBV and HCV related HCC.
    Hatanaka K; Kudo M; Fukunaga T; Ueshima K; Chung H; Minami Y; Sakaguchi Y; Hagiwara S; Orino A; Osaki Y
    Intervirology; 2007; 50(1):24-31. PubMed ID: 17164554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing relative roles of hepatitis B and C viruses in the aetiology of hepatocellular carcinoma in Greece. Epidemiological and clinical observations.
    Raptis I; Koskinas J; Emmanouil T; Hadziyannis S
    J Viral Hepat; 2003 Nov; 10(6):450-4. PubMed ID: 14633179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future.
    Yoshizawa H
    Oncology; 2002; 62 Suppl 1():8-17. PubMed ID: 11868791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study.
    Ikeda K; Marusawa H; Osaki Y; Nakamura T; Kitajima N; Yamashita Y; Kudo M; Sato T; Chiba T
    Ann Intern Med; 2007 May; 146(9):649-56. PubMed ID: 17470833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homeless patients with hepatocellular carcinoma in Osaka City, Japan.
    Sakai Y; Seki S; Nishiguchi S; Kuroki T; Kitada T; Enomoto M; Satake K; Monna T
    Hepatogastroenterology; 1999; 46(26):1106-10. PubMed ID: 10370675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus genotype 3 was associated with the development of hepatocellular carcinoma in Korea.
    Lee SS; Kim CY; Kim BR; Cha RR; Kim WS; Kim JJ; Lee JM; Kim HJ; Ha CY; Kim HJ; Kim TH; Jung WT; Lee OJ
    J Viral Hepat; 2019 Apr; 26(4):459-465. PubMed ID: 30516858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular evolutionary analysis predicts the incidence of hepatocellular carcinoma in the United States and Japan.
    Mizokami M; Tanaka Y
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S83-6. PubMed ID: 15316753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus 1b(II) infection and development of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma: a case-control study in Japan.
    Tanaka H; Tsukuma H; Yamano H; Okubo Y; Inoue A; Kasahara A; Hayashi N
    J Epidemiol; 1998 Oct; 8(4):244-9. PubMed ID: 9816816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data linkage to monitor hepatitis C-associated end-stage liver disease and hepatocellular carcinoma inpatient stays in England.
    Ireland G; Simmons R; Hickman M; Harris R; Ramsay M; Sabin C; Mandal S
    J Viral Hepat; 2020 Jan; 27(1):20-27. PubMed ID: 31505083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
    Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
    World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 2-year retrospective study of viral and host-associated risk factors in Pakistani hepatocellular carcinoma patients.
    Ul Abideen Z; Siddique S; Nasrullah I; Khan JS; Rehman S; Tong Y; Qamar R; Butt AM
    Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1103-1109. PubMed ID: 30829691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.
    Chen CL; Yang HI; Yang WS; Liu CJ; Chen PJ; You SL; Wang LY; Sun CA; Lu SN; Chen DS; Chen CJ
    Gastroenterology; 2008 Jul; 135(1):111-21. PubMed ID: 18505690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary liver cancer incidence-rates related to hepatitis-C virus infection: a correlational study in Osaka, Japan.
    Tanaka H; Hiyama T; Okubo Y; Kitada A; Fujimoto I
    Cancer Causes Control; 1994 Jan; 5(1):61-5. PubMed ID: 7510133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Why so high incidence of HCC in Japan?].
    Mizokami M
    Gan To Kagaku Ryoho; 2009 Jul; 36(7):1055-7. PubMed ID: 19620790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.